Funding for this research was provided by:
NIH Office of the Director (DP5 OD021403)
National Cancer Institute (R35 CA220481)
Received: 11 September 2018
Accepted: 11 September 2018
First Online: 19 September 2018
Ethics approval and consent to participate
: This study was approved by the Committee on Human Research of the University of California, San Francisco, with a waiver of patient consent.
: Not applicable.
: The authors declare that they have no competing interests related to this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.